Fecal transplantation successful for recurrent C. diff: 4 things to know

A new study, published in the Annals of Internal Medicine, examined the role of fecal microbiota transplantation for Clostridium difficile infection.

Here are four things to know:

1. Researchers conducted two randomized, controlled trials in which 28 case-series studies and five case reports were included.

2. Fecal microbiota transplantation was successful in 85 percent of recurrent CDI studies.

3. Fecal microbiota transplantation may have a substantial effect with few short-term adverse events for recurrent CDI, study authors concluded.

4. However, evidence is insufficient on fecal microbiota transplantation for refractory or initial CDI treatment, they note.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Whitepapers

Featured Webinars